$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Cancer is caused by the accumulation of mutations affecting genes that regulate normal cell growth. Mutation is a consequence of changes to the structure and sequence of the genome caused by damage to DNA. DNA damage can occur through a variety of process, including exogenous agents such as ionizing radiation, and as a by-product of normal cellular metabolism, such as spontaneous deamination of nucleotide bases or damage occurring by contact with reactive oxygen species1.
Although mammalian cells possess a range of repair activities which can reverse DNA damage or restore the sequence at break sites, mutations nonetheless accumulate throughout the lifetime of a cell. DNA damage can furthermore contribute to senescence and loss of potency of stem cells, two processes which are associated with aging-associated disease2. Understanding the repair of DNA damage is therefore of central importance in addressing two significant issues in public health. Increasing evidence suggests that mammalian DNA repair pathways can contribute to the evolution of the cancer cell genome3,4, making it even more imperative to understand the processes involved in suppressing mutation at the molecular level.
Direct visualization of chromosome aberrations is a powerful and quantitative means of determining the extent of genomic instability in a particular cell type. Condensed chromosomes from cells at metaphase can be isolated and inspected using light or fluorescent microscopy. Such cytogenetic approaches have been in practice for several decades and can be used to demonstrate the appearance of translocations or specific types of chromosome aberrations associated with loss of DNA repair activities. The protocol lends itself to several potential extensions: chromosomes can be labeled with probes for spectral karyotyping (SKY) or multicolor fluorescent in situ hybridization (mFISH) to identify translocations5,6. These techniques also enable the frequency of chromosome translocations and the structure of complex chromosome translocations to be determined, which provides additional information beyond what is possible with this protocol. Alternatively, sequence-specific probes can be generated and used to test the frequency of DNA breakage at selected genomic sites7.
In this protocol, we describe preparation of metaphase chromosome spreads from B lymphocytes. A fluorescently-labeled peptide nucleic acid (PNA) probe for telomeric repeats is used, which efficiently marks telomeres in metaphase chromosome spreads This protocol has several advantages. B cells can be induced to grow at high mitotic index so that high-quality spreads can consistently be produced. B cells from genetically-modified mice are also much less likely to contain secondary genetic mutations that can confound the analysis of the contribution of specific genes to genomic integrity. The PNA-FISH approach can be completed in one day, and allows more accurate scoring of chromosome breaks. By using this approach, particularly in combination with specific equipment described in this protocol, it is possible to produce very consistent, high-quality spreads and rapidly analyze the rate and type of genomic instability.